Literature DB >> 33334798

Leiomyoadenomatoid Tumor of Epididymis: A Variant of Adenomatoid Tumor.

Ahmed Shehabeldin1, Ghadah Al Sannaa1, Ziad El-Zaateri1, Lizmarie Andino2, Daniel Schmolze3, Darren Chapman4, Alberto Ayala1, Jae Y Ro5.   

Abstract

Adenomatoid tumor is a rare tumor of mesothelial origin, usually arising in the epididymis. It is the most common paratesticular tumor of middle-aged men. A rare variant of adenomatoid tumor is leiomyoadenomatoid tumor which is characterized by prominent spindle cell myoblastic and myofibroblastic proliferation in the background of an adenomatoid tumor with tubular spaces lined by mesothelial cells. In some cases, the spindle cell component obscures the adenomatoid tumor component, complicating accurate diagnosis. Here, we report two cases of paratesticular leiomyoadenomatoid tumor in 28-year-old and 50-year-old patients. The tumors from both cases were centered in the epididymis and measured 1.0 cm and 3.0 cm, respectively. Both had similar morphology with myofibroblastic proliferation in one case and myoblastic (smooth muscle) proliferation in the other. Both cases followed a benign course without local recurrence or distant metastasis for 14 and 22 months postoperatively, respectively. We propose the use of the term "adenomyomatoid tumor" to describe a neoplasm exhibiting adenomatoid tumor admixed with either leiomyomatous or myofibroblastic proliferation.
© 2020 by the Association of Clinical Scientists, Inc.

Entities:  

Keywords:  adenomatoid tumor; immunohistochemistry; leiomyoadenomatoid tumor; myoblast; myofibroblast; paratesticular

Mesh:

Year:  2020        PMID: 33334798

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  1 in total

1.  Leiomyoadenomatoid tumors: A type of rare benign epididymal tumor.

Authors:  Nasser Almohaya; Mohammed Almansori; Mohammed Sammour; Abdulbari Bin Ajjaj; Mohamed Tahar Yacoubi
Journal:  Urol Case Rep       Date:  2021-04-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.